Invesaro

Stocks EL Financial statements

Financial statements

ESTEE LAUDER COMPANIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ESTEE LAUDER COMPANIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue11,82413,68314,86314,29416,21517,73715,91015,60814,32615,049
Cost of revenue2,4342,8443,3873,5523,8344,3054,5644,4243,7293,687
Gross profit9,39010,83911,47610,74212,38113,43211,34611,18410,59711,362
Selling, general and administrative7,4608,5538,8578,6379,3719,8889,5759,6219,4569,685
Selling and marketing2,6893,2873,440
Operating expenses7,6868,7849,16310,1369,76310,2629,83710,21411,38210,582
Operating income1,7042,0552,3136062,6183,1701,509970-785780
Interest expense103128133161173167255378357334
Pre-tax income1,6171,9802,3071,0463,3313,0361,397772-1,040517
Income tax36186351335045662838736393335
Net income to minority interests7991212700
Net income1,2491,1081,7856842,8702,3901,006390-1,133182
EBITDA2,1682,5862,8701,2173,2693,8972,2531,795441,576
EPS, basic3.403.014.911.907.916.642.811.09-3.150.50
EPS, diluted3.352.954.821.867.796.552.791.08-3.150.50
Shares, basic (weighted)367368364361363360358359360362
Shares, diluted (weighted)373376370367368365361361360365
Dividend per share1.321.481.671.392.072.332.582.641.711.40

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents1,1362,1812,9875,0224,9583,9574,0293,3952,9213,498
Short-term investments605534
Receivables1,3951,4871,8311,1941,7021,6291,4521,7271,5301,518
Inventory1,4791,6182,0062,0622,5052,9202,9792,1752,0741,999
Other current assets349348388614603792679625544597
Total current assets4,9646,1687,2128,8929,7689,2989,1397,9227,0697,612
Property, plant and equipment1,6711,8232,0682,0552,2802,6503,1793,1363,1722,805
Lease right-of-use assets2,2822,1901,9491,7971,8331,9521,740
Goodwill1,9161,9261,8681,4012,6162,5212,4862,1432,1352,107
Intangible assets1,3271,2761,2032,3384,0953,4285,6025,1833,7593,579
Long-term investments1,026843177
Other non-current assets6645318058131,0221,0641,2121,4601,8051,919
Total assets11,56812,56713,15617,78121,97120,91023,41521,67719,89219,762
Accounts payable8351,1821,4901,1771,6921,8221,6701,4401,4971,578
Deferred revenue33314222322312323327314282
Short-term debt1891835161,222322689975043503
Total current liabilities2,8233,3104,6055,1795,2985,8156,2405,7025,4356,231
Long-term debt3,3833,3612,8964,9145,5375,1447,1177,2677,3146,803
Lease liabilities2,2782,1511,8681,6981,7011,7441,541
Other non-current liabilities9601,1861,2441,4482,0371,6511,9431,6931,5341,381
Total liabilities7,1667,8578,74513,81915,88015,32017,83016,36316,02715,956
Total debt3,3833,3612,8964,9145,5375,1447,1177,2677,3146,803
Paid-in capital3,5593,9724,4034,7905,3355,7966,1536,6857,0127,378
Retained earnings8,4529,0409,98410,13412,24413,91213,99113,42711,67211,341
Treasury stock-7,149-7,896-9,444-10,330-11,058-13,362-13,631-13,664-13,698-13,766
Other comprehensive income-484-434-563-665-470-762-934-1,140-1,127-1,153
Shareholders' equity4,3844,6884,3863,9356,0575,5905,5855,3143,865
Minority interests18222527340
Total equity4,4024,7104,4113,9626,0915,5905,5855,3143,8653,806
Total liabilities and equity11,56812,56713,15617,78121,97120,91023,41521,67719,89219,762

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income1,2561,1171,7946962,8752,4081,010409-1,133182
Depreciation and amortization464531557611651727744825829796
Stock-based compensation219236243213327331267325304310
Deferred income tax-118175-66-143-230-149-186-265-396-164
Change in receivables-92-105-169625-398-10185-2852308
Change in inventory-85-147-375-3-140-602-6476618451
Cash from operations1,7902,5622,5172,2803,6313,0401,7312,3601,2721,773
Capital expenditures-504-629-744-623-637-1,040-1,003-919-602-457
Acquisitions-1,67100-1,047-1,065-3000-5
Purchases of investments-1,267-478-14-5-42-10-8-18-1-35
Sales and maturities of investments1,2267491,22900003
Cash from investing-2,204-358473-1,698-1,864-945-3,217-960-623-489
Debt issued1,498
Stock issued14118219218021515188401553
Share buybacks-413-759-1,555-893-733-2,309-271-35-35-70
Dividends paid-486-546-609-503-753-840-925-947-618-508
Cash from financing630-1,172-2,1731,461-1,892-3,0361,590-2,035-1,144-712
Exchange rate effect613-11-861-60-321215
Net change in cash2221,0458062,035-64-1,00172-634-474577
Free cash flow1,2861,9331,7731,6572,9942,0007281,4416701,316
Interest paid96128131153166163235395353331
Income taxes paid456351588537664760665550630535

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $94.47 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin75.5%Gross profit / revenue.
Operating margin5.2%Operating income / revenue.
EBITDA margin10.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin3.4%Pre-tax income / revenue.
Net margin1.2%Net income / revenue.
FCF margin8.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin11.8%Cash from operations / revenue.
Effective tax rate64.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)0.9%Net income / average total assets.
SG&A / revenue64.4%Selling, general and administrative expense / revenue.
Stock-based pay / revenue2.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue3.0%Capital expenditures / revenue.
D&A / revenue5.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y5.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-1.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-1.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y7.2%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y0.0%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-1.7%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y-19.7%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y-21.5%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y3,482.0%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-11.2%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y-13.6%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y-43.4%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y-42.4%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 3y-43.6%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y-42.3%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y39.4%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y0.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-13.4%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y96.4%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y21.8%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-15.2%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y-18.1%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y-18.4%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y-7.5%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-0.7%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-5.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-2.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y1.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.22xCurrent assets / current liabilities.
Quick ratio0.81x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.56x(Cash + short-term investments) / current liabilities.
Debt / assets34.4%Total debt / total assets.
Liabilities / assets80.7%Total liabilities / total assets.
Net debt$3.31BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA2.10xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage2.34xOperating income / interest expense.
Working capital$1.38BCurrent assets - current liabilities.
Goodwill and intangibles / assets28.8%(Goodwill + intangible assets) / total assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.76xRevenue / average total assets.
Fixed asset turnover5.04xRevenue / average property, plant and equipment.
Inventory turnover1.81xCost of revenue / average inventory.
Days inventory202 days365 x average inventory / cost of revenue.
Receivables turnover9.87xRevenue / average receivables.
Days sales outstanding37 days365 x average receivables / revenue.
Days payables152 days365 x average accounts payable / cost of revenue.
Cash conversion cycle86 daysDays inventory + days sales outstanding - days payables.
FCF conversion723.1%Free cash flow / net income, when net income is positive.
Capex / operating cash flow25.8%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.50Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$0.50Net income per basic share, as reported (split-adjusted).
Revenue per share$41.25Revenue / diluted weighted shares.
FCF per share$3.61Free cash flow / diluted weighted shares.
Operating cash flow per share$4.86Cash from operations / diluted weighted shares.
Cash per share$9.59(Cash + short-term investments) / shares outstanding.
Dividend per share$1.40Dividend declared per common share (paid, when declared is not tagged).
Payout ratio279.1%Dividends paid / net income, when net income is positive.
Dividends / FCF38.6%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF5.3%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$34.18BShare price x shares outstanding.
Enterprise value$37.48BMarket cap + total debt - cash - short-term investments.
P/E188xMarket cap / net income. Only when net income is positive.
P/S2.27xMarket cap / revenue.
P/FCF26.0xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF19.3xMarket cap / cash from operations, when positive.
EV/Sales2.49xEnterprise value / revenue.
EV/EBIT48.1xEnterprise value / operating income, when both are positive.
EV/EBITDA23.8xEnterprise value / EBITDA, when both are positive.
EV/FCF28.5xEnterprise value / free cash flow, when both are positive.
FCF yield3.9%Free cash flow / market cap.
Earnings yield0.5%Net income / market cap (the inverse of P/E).
Dividend yield1.5%Dividends paid over the period / market cap.
Shareholder yield1.7%(Dividends paid + share buybacks) / market cap.
What was ESTEE LAUDER COMPANIES INC's revenue in fiscal 2026?

ESTEE LAUDER COMPANIES INC reported revenue of $15.05B for fiscal 2026, 5% higher than the year before.

Was ESTEE LAUDER COMPANIES INC profitable in fiscal 2026?

Yes. Net income was $182.0M, a net margin of 1.2%.

How much free cash flow did ESTEE LAUDER COMPANIES INC generate in fiscal 2026?

Cash from operations of $1.77B minus capital expenditures of $457.0M left free cash flow of $1.32B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ESTEE LAUDER COMPANIES INC